Abstract
Post stroke depression or PSD is believed to occur in ten to forty percent of all patients who survive stroke. These mood disturbances overlap with primary major depressive disorder in terms of symptom profile, natural history and response to antidepressant medications. Cognitive changes, especially impairments in executive functions, are commonly encountered in PSD. This may be the result of disruption to fronto-thalamo-cortical circuits in PSD. Both functional limitations following stroke and biological mechanisms may play important roles in the pathophysiology of PSD. Antidepressants are clinically effective in managing these mood disturbances and may have an important role in the prophylaxis of depression following stroke. PSD provides a naturalistic model that facilitates the study of the clinical correlates and neurobiological mechanisms that may be relevant in the pathophysiology of vascular depression.
Keywords: stroke, depression, location, executive dysfunction, norepinephrine, serotonin, antidepressants, prophylaxis
Current Neuropharmacology
Title: The Clinical Neuroscience of Post Stroke Depression
Volume: 2 Issue: 4
Author(s): Ebrahim Haroon and Anand Kumar
Affiliation:
Keywords: stroke, depression, location, executive dysfunction, norepinephrine, serotonin, antidepressants, prophylaxis
Abstract: Post stroke depression or PSD is believed to occur in ten to forty percent of all patients who survive stroke. These mood disturbances overlap with primary major depressive disorder in terms of symptom profile, natural history and response to antidepressant medications. Cognitive changes, especially impairments in executive functions, are commonly encountered in PSD. This may be the result of disruption to fronto-thalamo-cortical circuits in PSD. Both functional limitations following stroke and biological mechanisms may play important roles in the pathophysiology of PSD. Antidepressants are clinically effective in managing these mood disturbances and may have an important role in the prophylaxis of depression following stroke. PSD provides a naturalistic model that facilitates the study of the clinical correlates and neurobiological mechanisms that may be relevant in the pathophysiology of vascular depression.
Export Options
About this article
Cite this article as:
Haroon Ebrahim and Kumar Anand, The Clinical Neuroscience of Post Stroke Depression, Current Neuropharmacology 2004; 2 (4) . https://dx.doi.org/10.2174/1570159043359567
DOI https://dx.doi.org/10.2174/1570159043359567 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antidepressants: Update on Benefits and Risks
Current Psychopharmacology Redox Modification of Platelet Glycoproteins
Current Drug Targets Aging and Remodeling During Healing of the Wounded Heart: Current Therapies and Novel Drug Targets
Current Drug Targets Not a Painless Condition: Rheumatological and Musculoskeletal Symptoms in Type 2 Diabetes, and the Implications for Exercise Participation
Current Diabetes Reviews The Role of Diabetes in Molecular Pathogenesis of Cancer
Current Signal Transduction Therapy PREFACE: Is Renal Denervation Effective Option for Management of Hypertension in Asia?
Current Hypertension Reviews Biomarkers and Cellular Signal Detection for Alzheimer’s Disease, Stroke, and Immune System Mediated Disorders
Current Neurovascular Research Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia
Current Molecular Pharmacology Sudden Infant Death Syndrome: Implications of Altered Physiological Control During Sleep
Current Pediatric Reviews Structure and Function of the Von Willebrand Factor A1 Domain
Current Protein & Peptide Science Acute Decompensated Heart Failure Update
Current Cardiology Reviews Smart Delivery and Controlled Drug Release with Gold Nanoparticles: New Frontiers in Nanomedicine
Recent Patents on Nanomedicine Nocturnal Blood Pressure Abnormalities in Obstructive Sleep Apnea - Clinical Predictors
Current Respiratory Medicine Reviews Diabetic Cardiovascular Disease – AMP-Activated Protein Kinase (AMPK) as a Therapeutic Target
Cardiovascular & Hematological Agents in Medicinal Chemistry Visfatin/PBEF and Atherosclerosis-Related Diseases
Current Vascular Pharmacology Role of C-Reactive Protein in Acute Myocardial Infarction and Stroke: Possible Therapeutic Approaches
Current Pharmaceutical Biotechnology Inflammatory Cytokines, Growth Factors, and Depression
Current Pharmaceutical Design Antisense Therapy for Cardiovascular Diseases
Current Pharmaceutical Design The Pathobiology of Endothelin-1 in Vein Graft Disease: Are ETA Receptor Antagonists the Solution to Prevent Vein Graft Failure?
Current Vascular Pharmacology Current Status of Carotid Stenting
Current Vascular Pharmacology